JAMA Surg: Increased risk of postoperative adverse prognosis in patients with new coronary pneumonia

Recently, researchers examined the prognosis effect ofCOVID-19patients after surgerystudy was conducted in Italy and was conducted in general surgery,vascularsurgery, thoracic surgery, orthopaedics and neurosurgerynew coronary pneumoniapatients who tested positive for COVID-19 before or within 1 week of surgeryPatients who tested positive for COVID-19 and underwent surgery compared baselines with matching surgery patients who did notinfectedThe main endpoint of the study was the early surgical mortality and complications in patients with COVID-19, and the secondary endpoint was the establishment of a complication model to determine the effect of COVID-19 on adverse postoperative prognosis33 (80.5%) of the 41 patients who underwent emergency surgery were positive for the new coronavirus pneumonia before surgery and 8 (19.5%) within 5 days of surgeryOf the 123 participants (78 females, with an average age of 76.6 years), the 30-day mortality rate in the COVID-19 group was significantly higher than in the control group without COVID-19 (ratio: 9.5)The risk of postoperative complications also increased significantly in patients with neo-coronary pneumonia (OR:4.98), with lung complications being the most common (OR:35.62), but also a significant increase in the risk ofcomplications ofthrombosis (OR:13.2) Model studies determined that COVID-19 is an important factor in postoperative complications study found that patients with new coronary pneumonia had a significantly increased risk of postoperative mortality and complications, and that, where possible, COVID-19 patients should delay surgery